FindTrial
Sign In

The Study of Leucocyte Telomere Length in Newly diagnosed Type 2 Diabetic Patients with Depression

The Study of Leucocyte Telomere Length in Newly diagnosed Type 2 Diabetic Patients with Depression

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OCC-14004243
Enrollment
Unknown
Registered
2014-02-09
Start date
2011-01-15
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

type 2 diabetes

Interventions

T2DM:NA
control:NA

Sponsors

Tongji Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: The enrolled subjects were diagnosed with T2DM no more than 1 month and had not received any anti-diabetic agents yet.

Exclusion criteria

Exclusion criteria: The individual with pregnancy, acute inflammation, communicable diseases, cancer, stroke, severe cardiovascular disease, Alzheimer’s disease, dementia or severe cognitive disorders were excluded.

Design outcomes

Primary

MeasureTime frame
telomere length;HADS-D;—

Secondary

MeasureTime frame
HbA1c;FBG;—

Countries

China

Contacts

Public ContactYang Yan

Division of Endocrine, Tongji Hjospital, Tongji Medical College, Huazhong University of Science and Technology

darkwhite20112011@gmail.com+86 18627021691

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026